Cointime

Avexegen Therapeutics

company

About

Avexegen Therapeutics is an early stage development company working on novel and revolutionary therapies for the $10 Billion GI Market.

  • 1 - 10

Highlights

Total Funding Amount
$2.94M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.94M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.94M
Avexegen Therapeutics has raised a total of $2.94M in funding over 2 rounds. Their latest funding was raised on Feb 15, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 15, 2021 Grant $2.94M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Avexegen Therapeutics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Grant
Cointime
เนื้อหา
บริษัท